Viewing Study NCT02023333


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-03-07 @ 11:00 PM
Study NCT ID: NCT02023333
Status: COMPLETED
Last Update Posted: 2025-08-27
First Post: 2013-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module